Last reviewed · How we verify
NCT05408936: SGLT2HgB
SGLT2 Inhibitors and Effects on Hematopoiesis, Inflammation and Metabolic Markers
trial testing SGLT2 inhibitor in Diabetes Mellitus, Type 2 in 80 participants. Participants enrolled and being followed up; not accepting new ones.
1 December 2023
Quick facts
| Lead sponsor | University of Patras |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 80 |
| Start date | 3 June 2022 |
| Primary completion | 1 December 2023 |
| Estimated completion | 1 June 2024 |
| Sites | 1 location across Greece |
Drugs / interventions tested
- SGLT2 inhibitor — full drug profile →
Conditions studied
- Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →
Sponsor
University of Patras
Who can join
18 and older, any sex, with Diabetes Mellitus, Type 2. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Study of the response to SGLT2 inhibitors in type 2 diabetic patients with relevance to the erythropoesis and indexes of cardiorenal function. The study enrolls type 2 diabetic patients in whom the introduction of a SGLT2 inhibitor is deemed necessary as part of their routine treatment during their visit to our outpatient diabetes unit. A whole blood, a serum and a urine sample is obtained before and one month after the initiation of treatment with a SGLT2 inhibitor.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Mechanisms of diabetic cardiomyopathy: Focus on inflammation.
Bellemare M, Bourcier L, Iglesies-Grau J, Boulet J, et al · · 2025 · cited 20× · PMID 39930551 · DOI 10.1111/dom.16242
Verify or expand the search:
- PubMed search for NCT05408936
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of SGLT2 inhibitor
Trials testing the same drug.
- NCT07360457 — GLP1 Analogues and the Risk of Osteoarthritis · not yet recruiting
- NCT07172971 — Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy · Phase 1 · not yet recruiting
- NCT07334145 — Effect of SGLT2 Inhibitors on Anemic CKD Patients · not yet recruiting
- NCT07063316 — SGLT2 Inhibitors and Renal Anemia in Japan: RWD · active not recruiting
- NCT06350487 — The Efficacy of Enavogliflozin in Heart Failure With Preserved Ejection Fraction · Phase 4 · not yet recruiting
Other recruiting trials for Diabetes Mellitus, Type 2
Currently open trials in the same condition.
- NCT07415954 — A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 · Phase 2 · recruiting
- NCT07532863 — A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Part · recruiting
- NCT07336329 — Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use · NA · recruiting
- NCT07242469 — A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006) · Phase 1 · recruiting
- NCT07444203 — Transformative Research in Diabetic Nephropathy 2.0 · recruiting
Other University of Patras trials
Trials by the same sponsor.
- NCT07472894 — AI-INFORMED PEER-MENTORING BEHAVIORAL INTERVENTION FOR ANXIETY AND DEPRESSION PRIMARY PREVENTION IN YOUTH · NA · not yet recruiting
- NCT07334392 — Impact of a Multicomponent Exercise Program on Cognitive and Functional Outcomes in Patients With Mild Cognitive Impairm · NA · recruiting
- NCT07389993 — Diaphragm and Breathing Muscle Characteristics in Women With and Without Diastasis Recti Abdominis After Childbirth · recruiting
- NCT06848517 — Synchronous and Asynchronous Telerehabilitation for Women With Urinary Incontinence · NA · recruiting
- NCT06161324 — Tele-rehabilitation for Women With Urinary Incontinence · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05408936 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Patras
- Last refreshed: 14 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05408936.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing